How to Choose the Biologic Therapy in a Bio-naïve Patient with Inflammatory Bowel Disease

The availability of biologic therapies in inflammatory bowel disease (IBD) is increasing significantly. This represents more options to treat patients, but also more difficulties in choosing the therapies, especially in the context of bio-naïve patients. Most evidence of safety and efficacy came fro...

Descripción completa

Detalles Bibliográficos
Autores principales: Laredo, Viviana, Gargallo-Puyuelo, Carla J., Gomollón, Fernando
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2022
Materias:
Review
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8837085/
https://www.ncbi.nlm.nih.gov/pubmed/35160280
http://dx.doi.org/10.3390/jcm11030829

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8837085/
https://www.ncbi.nlm.nih.gov/pubmed/35160280
http://dx.doi.org/10.3390/jcm11030829

Ejemplares similares